世界の抗核抗体（ANA）検査市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Antinuclear Antibody (ANA) Test Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z01000 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、抗核抗体（ANA）検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗核抗体（ANA）検査の種類別市場規模（試薬・アッセイキット、システム、ソフトウェア・サービス）、用途別市場規模（病院、臨床検査室、医師室検査室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗核抗体（ANA）検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Bio-Rad Laboratories, Inc、ERBA Diagnostics, Inc、Trinity Biotech plc、Thermo Fisher Scientific, Inc、Antibodies, Inc、EUROIMMUN AG、Immuno Concepts、Inova Diagnostics、Zeus Scientific ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：試薬・アッセイキット、システム、ソフトウェア・サービス ・用途別分析2016年-2026年：病院、臨床検査室、医師室検査室、その他 ・抗核抗体（ANA）検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗核抗体（ANA）検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗核抗体（ANA）検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗核抗体（ANA）検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗核抗体（ANA）検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Antinuclear Antibody (ANA) Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Antinuclear Antibody (ANA) Test size is estimated to be USD 1216.2 million in 2025 from USD 935.4 million in 2019, with a change XX% between 2019 and 2020. The global Antinuclear Antibody (ANA) Test market size is expected to grow at a CAGR of 6.8% for the next five years.

Market segmentation
Antinuclear Antibody (ANA) Test market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Reagents & Assay Kits
Systems
Software & Service

Market segment by Application, can be divided into
Hospitals
Clinical Laboratories
Physician Office Laboratories
Others

Market segment by players, this report covers
Abbott
Bio-Rad Laboratories, Inc
ERBA Diagnostics, Inc
Trinity Biotech plc
Thermo Fisher Scientific, Inc
Antibodies, Inc
EUROIMMUN AG
Immuno Concepts
Inova Diagnostics
Zeus Scientific

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Antinuclear Antibody (ANA) Test
1.2 Classification of Antinuclear Antibody (ANA) Test by Type
1.2.1 Overview: Global Antinuclear Antibody (ANA) Test Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Antinuclear Antibody (ANA) Test Revenue Market Share by Type in 2020
1.2.3 Reagents & Assay Kits
1.2.4 Systems
1.2.5 Software & Service
1.3 Global Antinuclear Antibody (ANA) Test Market by Application
1.3.1 Overview: Global Antinuclear Antibody (ANA) Test Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Physician Office Laboratories
1.3.5 Others
1.4 Global Antinuclear Antibody (ANA) Test Market Size & Forecast
1.5 Global Antinuclear Antibody (ANA) Test Market Size and Forecast by Region
1.5.1 Global Antinuclear Antibody (ANA) Test Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Antinuclear Antibody (ANA) Test Market Size by Region, (2016-2021)
1.5.3 North America Antinuclear Antibody (ANA) Test Market Size and Prospect (2016-2026)
1.5.4 Europe Antinuclear Antibody (ANA) Test Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size and Prospect (2016-2026)
1.5.6 South America Antinuclear Antibody (ANA) Test Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Antinuclear Antibody (ANA) Test Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Antinuclear Antibody (ANA) Test Market Drivers
1.6.2 Antinuclear Antibody (ANA) Test Market Restraints
1.6.3 Antinuclear Antibody (ANA) Test Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Antinuclear Antibody (ANA) Test Product and Solutions
2.1.4 Abbott Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Bio-Rad Laboratories, Inc
2.2.1 Bio-Rad Laboratories, Inc Details
2.2.2 Bio-Rad Laboratories, Inc Major Business
2.2.3 Bio-Rad Laboratories, Inc Antinuclear Antibody (ANA) Test Product and Solutions
2.2.4 Bio-Rad Laboratories, Inc Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bio-Rad Laboratories, Inc Recent Developments and Future Plans
2.3 ERBA Diagnostics, Inc
2.3.1 ERBA Diagnostics, Inc Details
2.3.2 ERBA Diagnostics, Inc Major Business
2.3.3 ERBA Diagnostics, Inc Antinuclear Antibody (ANA) Test Product and Solutions
2.3.4 ERBA Diagnostics, Inc Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ERBA Diagnostics, Inc Recent Developments and Future Plans
2.4 Trinity Biotech plc
2.4.1 Trinity Biotech plc Details
2.4.2 Trinity Biotech plc Major Business
2.4.3 Trinity Biotech plc Antinuclear Antibody (ANA) Test Product and Solutions
2.4.4 Trinity Biotech plc Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Trinity Biotech plc Recent Developments and Future Plans
2.5 Thermo Fisher Scientific, Inc
2.5.1 Thermo Fisher Scientific, Inc Details
2.5.2 Thermo Fisher Scientific, Inc Major Business
2.5.3 Thermo Fisher Scientific, Inc Antinuclear Antibody (ANA) Test Product and Solutions
2.5.4 Thermo Fisher Scientific, Inc Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Thermo Fisher Scientific, Inc Recent Developments and Future Plans
2.6 Antibodies, Inc
2.6.1 Antibodies, Inc Details
2.6.2 Antibodies, Inc Major Business
2.6.3 Antibodies, Inc Antinuclear Antibody (ANA) Test Product and Solutions
2.6.4 Antibodies, Inc Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Antibodies, Inc Recent Developments and Future Plans
2.7 EUROIMMUN AG
2.7.1 EUROIMMUN AG Details
2.7.2 EUROIMMUN AG Major Business
2.7.3 EUROIMMUN AG Antinuclear Antibody (ANA) Test Product and Solutions
2.7.4 EUROIMMUN AG Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 EUROIMMUN AG Recent Developments and Future Plans
2.8 Immuno Concepts
2.8.1 Immuno Concepts Details
2.8.2 Immuno Concepts Major Business
2.8.3 Immuno Concepts Antinuclear Antibody (ANA) Test Product and Solutions
2.8.4 Immuno Concepts Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Immuno Concepts Recent Developments and Future Plans
2.9 Inova Diagnostics
2.9.1 Inova Diagnostics Details
2.9.2 Inova Diagnostics Major Business
2.9.3 Inova Diagnostics Antinuclear Antibody (ANA) Test Product and Solutions
2.9.4 Inova Diagnostics Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Inova Diagnostics Recent Developments and Future Plans
2.10 Zeus Scientific
2.10.1 Zeus Scientific Details
2.10.2 Zeus Scientific Major Business
2.10.3 Zeus Scientific Antinuclear Antibody (ANA) Test Product and Solutions
2.10.4 Zeus Scientific Antinuclear Antibody (ANA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Zeus Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Antinuclear Antibody (ANA) Test Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Antinuclear Antibody (ANA) Test Players Market Share
3.2.2 Top 10 Antinuclear Antibody (ANA) Test Players Market Share
3.2.3 Market Competition Trend
3.3 Antinuclear Antibody (ANA) Test Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Antinuclear Antibody (ANA) Test Revenue and Market Share by Type (2016-2021)
4.2 Global Antinuclear Antibody (ANA) Test Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Antinuclear Antibody (ANA) Test Revenue Market Share by Application (2016-2021)
5.2 Antinuclear Antibody (ANA) Test Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Antinuclear Antibody (ANA) Test Revenue by Type (2016-2026)
6.2 North America Antinuclear Antibody (ANA) Test Revenue by Application (2016-2026)
6.3 North America Antinuclear Antibody (ANA) Test Market Size by Country
6.3.1 North America Antinuclear Antibody (ANA) Test Revenue by Country (2016-2026)
6.3.2 United States Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
6.3.3 Canada Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
6.3.4 Mexico Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Antinuclear Antibody (ANA) Test Revenue by Type (2016-2026)
7.2 Europe Antinuclear Antibody (ANA) Test Revenue by Application (2016-2026)
7.3 Europe Antinuclear Antibody (ANA) Test Market Size by Country
7.3.1 Europe Antinuclear Antibody (ANA) Test Revenue by Country (2016-2026)
7.3.2 Germany Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
7.3.3 France Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
7.3.5 Russia Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
7.3.6 Italy Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Type (2016-2026)
8.2 Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Application (2016-2026)
8.3 Asia-Pacific Antinuclear Antibody (ANA) Test Market Size by Region
8.3.1 Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Region (2016-2026)
8.3.2 China Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
8.3.3 Japan Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
8.3.4 South Korea Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
8.3.5 India Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
8.3.7 Australia Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Antinuclear Antibody (ANA) Test Revenue by Type (2016-2026)
9.2 South America Antinuclear Antibody (ANA) Test Revenue by Application (2016-2026)
9.3 South America Antinuclear Antibody (ANA) Test Market Size by Country
9.3.1 South America Antinuclear Antibody (ANA) Test Revenue by Country (2016-2026)
9.3.2 Brazil Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
9.3.3 Argentina Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Type (2016-2026)
10.2 Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Application (2016-2026)
10.3 Middle East & Africa Antinuclear Antibody (ANA) Test Market Size by Country
10.3.1 Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Country (2016-2026)
10.3.2 Turkey Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
10.3.4 UAE Antinuclear Antibody (ANA) Test Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Antinuclear Antibody (ANA) Test Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Antinuclear Antibody (ANA) Test Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Antinuclear Antibody (ANA) Test Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Antinuclear Antibody (ANA) Test Revenue (USD Million) by Region (2016-2021)
Table 5. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Antinuclear Antibody (ANA) Test Product and Solutions
Table 9. Abbott Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bio-Rad Laboratories, Inc Corporate Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories, Inc Major Business
Table 12. Bio-Rad Laboratories, Inc Antinuclear Antibody (ANA) Test Product and Solutions
Table 13. Bio-Rad Laboratories, Inc Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ERBA Diagnostics, Inc Corporate Information, Head Office, and Major Competitors
Table 15. ERBA Diagnostics, Inc Major Business
Table 16. ERBA Diagnostics, Inc Antinuclear Antibody (ANA) Test Product and Solutions
Table 17. ERBA Diagnostics, Inc Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Trinity Biotech plc Corporate Information, Head Office, and Major Competitors
Table 19. Trinity Biotech plc Major Business
Table 20. Trinity Biotech plc Antinuclear Antibody (ANA) Test Product and Solutions
Table 21. Trinity Biotech plc Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Thermo Fisher Scientific, Inc Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific, Inc Major Business
Table 24. Thermo Fisher Scientific, Inc Antinuclear Antibody (ANA) Test Product and Solutions
Table 25. Thermo Fisher Scientific, Inc Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Antibodies, Inc Corporate Information, Head Office, and Major Competitors
Table 27. Antibodies, Inc Major Business
Table 28. Antibodies, Inc Antinuclear Antibody (ANA) Test Product and Solutions
Table 29. Antibodies, Inc Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. EUROIMMUN AG Corporate Information, Head Office, and Major Competitors
Table 31. EUROIMMUN AG Major Business
Table 32. EUROIMMUN AG Antinuclear Antibody (ANA) Test Product and Solutions
Table 33. EUROIMMUN AG Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Immuno Concepts Corporate Information, Head Office, and Major Competitors
Table 35. Immuno Concepts Major Business
Table 36. Immuno Concepts Antinuclear Antibody (ANA) Test Product and Solutions
Table 37. Immuno Concepts Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Inova Diagnostics Corporate Information, Head Office, and Major Competitors
Table 39. Inova Diagnostics Major Business
Table 40. Inova Diagnostics Antinuclear Antibody (ANA) Test Product and Solutions
Table 41. Inova Diagnostics Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Zeus Scientific Corporate Information, Head Office, and Major Competitors
Table 43. Zeus Scientific Major Business
Table 44. Zeus Scientific Antinuclear Antibody (ANA) Test Product and Solutions
Table 45. Zeus Scientific Antinuclear Antibody (ANA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Antinuclear Antibody (ANA) Test Revenue (USD Million) by Players (2019-2021)
Table 47. Global Antinuclear Antibody (ANA) Test Revenue Share by Players (2019-2021)
Table 48. Breakdown of Antinuclear Antibody (ANA) Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Antinuclear Antibody (ANA) Test Players Head Office, Products and Services Provided
Table 50. Antinuclear Antibody (ANA) Test Mergers & Acquisitions in the Past Five Years
Table 51. Antinuclear Antibody (ANA) Test New Entrants and Expansion Plans
Table 52. Global Antinuclear Antibody (ANA) Test Revenue (USD Million) by Type (2016-2021)
Table 53. Global Antinuclear Antibody (ANA) Test Revenue Share by Type (2016-2021)
Table 54. Global Antinuclear Antibody (ANA) Test Revenue Forecast by Type (2021-2026)
Table 55. Global Antinuclear Antibody (ANA) Test Revenue by Application (2016-2021)
Table 56. Global Antinuclear Antibody (ANA) Test Revenue Forecast by Application (2021-2026)
Table 57. North America Antinuclear Antibody (ANA) Test Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Antinuclear Antibody (ANA) Test Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Antinuclear Antibody (ANA) Test Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Antinuclear Antibody (ANA) Test Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Antinuclear Antibody (ANA) Test Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Antinuclear Antibody (ANA) Test Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Antinuclear Antibody (ANA) Test Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Antinuclear Antibody (ANA) Test Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Antinuclear Antibody (ANA) Test Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Antinuclear Antibody (ANA) Test Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Antinuclear Antibody (ANA) Test Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Antinuclear Antibody (ANA) Test Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Antinuclear Antibody (ANA) Test Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Antinuclear Antibody (ANA) Test Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Antinuclear Antibody (ANA) Test Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Antinuclear Antibody (ANA) Test Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Antinuclear Antibody (ANA) Test Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Antinuclear Antibody (ANA) Test Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Antinuclear Antibody (ANA) Test Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Antinuclear Antibody (ANA) Test Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Antinuclear Antibody (ANA) Test Picture
Figure 2. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Type in 2020
Figure 3. Reagents & Assay Kits
Figure 4. Systems
Figure 5. Software & Service
Figure 6. Antinuclear Antibody (ANA) Test Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinical Laboratories Picture
Figure 9. Physician Office Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Antinuclear Antibody (ANA) Test Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Antinuclear Antibody (ANA) Test Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Region (2016-2026)
Figure 14. Global Antinuclear Antibody (ANA) Test Revenue Market Share by Region in 2020
Figure 15. North America Antinuclear Antibody (ANA) Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Antinuclear Antibody (ANA) Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Antinuclear Antibody (ANA) Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Antinuclear Antibody (ANA) Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Antinuclear Antibody (ANA) Test Market Drivers
Figure 20. Antinuclear Antibody (ANA) Test Market Restraints
Figure 21. Antinuclear Antibody (ANA) Test Market Trends
Figure 22. Abbott Recent Developments and Future Plans
Figure 23. Bio-Rad Laboratories, Inc Recent Developments and Future Plans
Figure 24. ERBA Diagnostics, Inc Recent Developments and Future Plans
Figure 25. Trinity Biotech plc Recent Developments and Future Plans
Figure 26. Thermo Fisher Scientific, Inc Recent Developments and Future Plans
Figure 27. Antibodies, Inc Recent Developments and Future Plans
Figure 28. EUROIMMUN AG Recent Developments and Future Plans
Figure 29. Immuno Concepts Recent Developments and Future Plans
Figure 30. Inova Diagnostics Recent Developments and Future Plans
Figure 31. Zeus Scientific Recent Developments and Future Plans
Figure 33. Global Antinuclear Antibody (ANA) Test Revenue Share by Players in 2020
Figure 34. Antinuclear Antibody (ANA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Antinuclear Antibody (ANA) Test Revenue Market Share in 2020
Figure 36. Global Top 10 Players Antinuclear Antibody (ANA) Test Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Antinuclear Antibody (ANA) Test Revenue Share by Type in 2020
Figure 39. Global Antinuclear Antibody (ANA) Test Market Share Forecast by Type (2021-2026)
Figure 40. Global Antinuclear Antibody (ANA) Test Revenue Share by Application in 2020
Figure 41. Global Antinuclear Antibody (ANA) Test Market Share Forecast by Application (2021-2026)
Figure 42. North America Antinuclear Antibody (ANA) Test Sales Market Share by Type (2016-2026)
Figure 43. North America Antinuclear Antibody (ANA) Test Sales Market Share by Application (2016-2026)
Figure 44. North America Antinuclear Antibody (ANA) Test Revenue Market Share by Country (2016-2026)
Figure 45. United States Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Antinuclear Antibody (ANA) Test Sales Market Share by Type (2016-2026)
Figure 49. Europe Antinuclear Antibody (ANA) Test Sales Market Share by Application (2016-2026)
Figure 50. Europe Antinuclear Antibody (ANA) Test Revenue Market Share by Country (2016-2026)
Figure 51. Germany Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Antinuclear Antibody (ANA) Test Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Antinuclear Antibody (ANA) Test Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Antinuclear Antibody (ANA) Test Revenue Market Share by Region (2016-2026)
Figure 59. China Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Antinuclear Antibody (ANA) Test Sales Market Share by Type (2016-2026)
Figure 66. South America Antinuclear Antibody (ANA) Test Sales Market Share by Application (2016-2026)
Figure 67. South America Antinuclear Antibody (ANA) Test Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Antinuclear Antibody (ANA) Test Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Antinuclear Antibody (ANA) Test Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Antinuclear Antibody (ANA) Test Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Antinuclear Antibody (ANA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

---